Anticoagulant Sodium Citrate Solution
Product Images NDC 76297-006

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Anticoagulant Sodium Citrate (NDC 76297-006). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Laboratorios Grifols Sa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton

Carton
Anticoagulant Sodium Citrate 4% w/v solution in 250mL USP container, intended for use with automated apheresis devices only. This prescription-only solution must not be directly infused into veins. It is understandable to store the solution between 20°C to 25°C, with excursions allowed between 15°C to 30°C as controlled in room temperature. The solution is safe for brief exposure up to 40°C, and it is essential to protect from freezing. The product's manufacturer is Laboratorion Gifls, based in Spain. The code NDG 76297-006-01 is imprinted on the container, along with the control and lot numbers.*
FDA Label Image

Carton (Container 76297 006 02)

Carton (Container 76297 006 02)
This is a description of Anticoagulant Sodium Citrate 4% w/v Solution, USP, intended to be used only with automated apheresis devices. It contains Sodium Citrate {Dihydrate), USP 4.0g with the pH adjusted with Citric Acid, Monohytdrate, USP. The solution is stored at 20° to 25°C (68° to 77°F) and brief exposure up to 40°C (104°F) does not adversely affect the product. It is highly recommended to discard any unused portion. This product is manufactured by Laboratorios Grifols, S.A. SPAIN.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.